IP Library › Granted Patent US 11,753,394
Granted Patent B2
US 11,753,394 · App. 17/324,867 · Granted Sep 12, 2023

Synthesis of omecamtiv mecarbil

Inventors: Sebastien Caille (Thousand Oaks, CA); Kyle Quasdorf (Thousand Oaks, CA); Philipp C. Roosen (Thousand Oaks, CA); Xianqing Shi (Newbury Park, CA); Andrew Cosbie (Ventura, CA); Fang Wang (Simi Valley, CA); Zufan Wu (Walnut, CA); Archana Neergunda (Simi Valley, CA); Bin Peter Quan (Thousand Oaks, CA); Lianxiu Guan (Camarillo, CA)
Assignee: AMGEN INC.
C07D401/12C07D241/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,753,394
App. No.
17/324,867
Granted
Sep 12, 2023
Kind
B2
Abstract

Provided herein is a synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates.

Claims (14)

1. A process for synthesizing phenyl (6-methylpyridin-3-yl) carbamate

comprising admixing 5-amino-2-methylpyridine

and phenyl chloroformate in acetonitrile to form PCAR, wherein the admixing is performed in the absence of N-methyl pyrrolidinone (NMP) and wherein purity of the APYR is ≥99 LC area %.

2. The process of claim 1 , wherein the admixing is performed at a temperature of 15 to 30° C. for 1 to 15 hours.

3. The process of claim 1 , wherein the PCAR is formed as a hydrochloride salt.

4. The process of claim 1 , further comprising preparing APYR by a process comprising:

(i) hydrogenating 2-methyl-5-nitropyridine

in the presence of a palladium catalyst to form crude APYR; and

(ii) crystallizing APYR from the crude APYR in isopropyl acetate and heptane.

5. The process of claim 4 , further comprising, prior to step (i), washing NPYR in isopropyl acetate with aqueous sodium hydroxide, followed by admixing the washed NPYR in isopropyl acetate with charcoal.

6. The process of claim 1 , further comprising, prior to admixing APYR and phenyl chloroformate, purifying APYR by a process comprising:

(i) washing an isopropyl acetate solution of crude APYR, wherein the crude APYR comprises up to 10 wt % APYR hydrochloride, with aqueous sodium hydroxide, and admixing the washed APYR with charcoal to form an APYR solution after filtration; and

(ii) crystallizing APYR from the APYR solution of step (i) from isopropyl acetate and heptane.

7. The process of claim 1 , further comprising crystallizing PCAR.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2021
From: CAILLE, SEBASTIEN; QUASDORF, KYLE; ROOSEN, PHILIPP; SHI, XIANQING; COSBIE, ANDREW; WANG, FANG; WU, ZUFAN; NEERGUNDA, ARCHANA; QUAN, BIN PETER; GUAN, LIANXIU
To: AMGEN, INC.
Reel/Frame 057090/0899 →
Continuity (4)
Division 16607940
Provisional Application 62664363 · Apr 30, 2018
Provisional Application 62527174 · Jun 30, 2017
Related Publication 20210371397A1 · Dec 2, 2021
Cited By (9)
US 12,194,039 US 12,221,417 US 12,264,133 US 12,269,811 US 12,275,704 US 12,295,952 US 12,442,027 US 12,583,821 US 12,612,366